Published in Immunol Res on January 01, 2006
Type I interferon and systemic lupus erythematosus. J Interferon Cytokine Res (2011) 1.18
Spontaneous regression of malignant tumors: Importance of the immune system and other factors (Review). Oncol Lett (2010) 1.16
Changes in apoptotic gene expression in lymphocytes from rheumatoid arthritis and systemic lupus erythematosus patients compared with healthy lymphocytes. J Clin Immunol (2010) 0.92
Complement activation in acetaminophen-induced liver injury in mice. J Pharmacol Exp Ther (2012) 0.91
Modulatory function of invariant natural killer T cells in systemic lupus erythematosus. Clin Dev Immunol (2012) 0.80
Autoantibodies associated with prenatal and childhood exposure to environmental chemicals in Faroese children. Toxicol Sci (2014) 0.78
Susceptibility to acute rheumatic fever based on differential expression of genes involved in cytotoxicity, chemotaxis, and apoptosis. Infect Immun (2013) 0.75
Measurement of erythrocyte C4d and complement receptor 1 in systemic lupus erythematosus. Arthritis Rheum (2004) 2.16
Erythrocyte C3d and C4d for monitoring disease activity in systemic lupus erythematosus. Arthritis Rheum (2010) 1.67
The search for lupus biomarkers. Best Pract Res Clin Rheumatol (2009) 1.26
Biomarkers for systemic lupus erythematosus: a review and perspective. Curr Opin Rheumatol (2005) 1.17
Cardiovascular disease in autoimmune rheumatic diseases. Autoimmun Rev (2013) 1.14
Biomarkers for systemic lupus erythematosus. Transl Res (2012) 1.01
Platelet C4d is highly specific for systemic lupus erythematosus. Arthritis Rheum (2006) 1.01
Reticulocytes bearing C4d as biomarkers of disease activity for systemic lupus erythematosus. Arthritis Rheum (2005) 0.98
Complement as a source of biomarkers in systemic lupus erythematosus: past, present, and future. Curr Rheumatol Rep (2004) 0.95
Sustained muscle expression of dystrophin from a high-capacity adenoviral vector with systemic gene transfer of T cell costimulatory blockade. Mol Ther (2004) 0.93
Complement proteins C3 and C4 bind to collagen and elastin in the vascular wall: a potential role in vascular stiffness and atherosclerosis. Clin Transl Sci (2011) 0.91
Evidence for a perforin-mediated mechanism controlling cardiac inflammation in Trypanosoma cruzi infection. Int J Exp Pathol (2002) 0.91
Increased erythrocyte C4D is associated with known alloantibody and autoantibody markers of antibody-mediated rejection in human lung transplant recipients. J Heart Lung Transplant (2010) 0.88
Sulphonation of dehydroepiandrosterone and neurosteroids: molecular cloning, expression, and functional characterization of a novel zebrafish SULT2 cytosolic sulphotransferase. Biochem J (2003) 0.88
Platelet C4d is associated with acute ischemic stroke and stroke severity. Stroke (2008) 0.88
Biomarkers in systemic lupus erythematosus: challenges and prospects for the future. Ther Adv Musculoskelet Dis (2013) 0.88
Cleavage of CD14 and LBP by a protease from Prevotella intermedia. Arch Microbiol (2003) 0.86
Relative contributions of age and atherosclerosis to vascular stiffness. Clin Transl Sci (2008) 0.85
Sulfation of hydroxychlorobiphenyls. Molecular cloning, expression, and functional characterization of zebrafish SULT1 sulfotransferases. Eur J Biochem (2003) 0.82
Lymphocyte-bound complement activation products as biomarkers for diagnosis of systemic lupus erythematosus. Clin Transl Sci (2009) 0.81
cDNA cloning, expression, and functional characterization of a zebrafish SULT1 cytosolic sulfotransferase. Arch Biochem Biophys (2003) 0.81
Relation of platelet C4d with all-cause mortality and ischemic stroke in patients with systemic lupus erythematosus. Transl Stroke Res (2013) 0.81
Identification of a novel estrogen-sulfating cytosolic SULT from zebrafish: molecular cloning, expression, characterization, and ontogeny study. Biochem Biophys Res Commun (2005) 0.80
Cell-bound complement activation products (CB-CAPs) as a source of lupus biomarkers. Adv Exp Med Biol (2006) 0.80
Apoptosis and immune responses to self. Rheum Dis Clin North Am (2004) 0.78
New advances in measurement of complement activation: lessons of systemic lupus erythematosus. Curr Rheumatol Rep (2004) 0.78
Cell-bound complement biomarkers for systemic lupus erythematosus: from benchtop to bedside. Rheum Dis Clin North Am (2010) 0.78
Apoptosis, complement and systemic lupus erythematosus: a mechanistic view. Curr Dir Autoimmun (2004) 0.77
The lupus biomarker odyssey: one experience. Methods Mol Biol (2014) 0.76
Mannose-binding lectin is a disease-modifying factor in North American patients with systemic lupus erythematosus. J Rheumatol (2007) 0.76